Short Interest in ARYA Sciences Acquisition Corp IV (NASDAQ:ARYD) Grows By 400.0%

ARYA Sciences Acquisition Corp IV (NASDAQ:ARYDGet Free Report) saw a significant increase in short interest during the month of April. As of April 15th, there was short interest totalling 500 shares, an increase of 400.0% from the March 31st total of 100 shares. Based on an average daily trading volume, of 40,500 shares, the short-interest ratio is currently 0.0 days. Approximately 0.0% of the shares of the stock are short sold.

ARYA Sciences Acquisition Corp IV Price Performance

ARYA Sciences Acquisition Corp IV stock remained flat at $11.33 during midday trading on Friday. The firm has a 50 day moving average of $11.26 and a 200-day moving average of $11.05. ARYA Sciences Acquisition Corp IV has a 12 month low of $10.41 and a 12 month high of $11.39.

Hedge Funds Weigh In On ARYA Sciences Acquisition Corp IV

Hedge funds and other institutional investors have recently added to or reduced their stakes in the company. Virtu Financial LLC purchased a new stake in ARYA Sciences Acquisition Corp IV during the fourth quarter valued at approximately $204,000. Mizuho Securities USA LLC raised its position in ARYA Sciences Acquisition Corp IV by 6.4% during the third quarter. Mizuho Securities USA LLC now owns 104,345 shares of the company’s stock valued at $1,116,000 after purchasing an additional 6,278 shares during the period. Hsbc Holdings PLC purchased a new stake in ARYA Sciences Acquisition Corp IV during the fourth quarter valued at approximately $1,630,000. Berkley W R Corp raised its position in ARYA Sciences Acquisition Corp IV by 24.3% during the fourth quarter. Berkley W R Corp now owns 188,862 shares of the company’s stock valued at $2,055,000 after purchasing an additional 36,888 shares during the period. Finally, Cowen AND Company LLC raised its position in ARYA Sciences Acquisition Corp IV by 85.1% during the third quarter. Cowen AND Company LLC now owns 192,561 shares of the company’s stock valued at $2,084,000 after purchasing an additional 88,505 shares during the period. 48.08% of the stock is owned by institutional investors.

ARYA Sciences Acquisition Corp IV Company Profile

(Get Free Report)

Arya Sciences Acquisition Corp IV does not have significant operations. The company intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. It focuses on acquiring North American or European companies in the life sciences and medical technology sectors.

Featured Stories

Receive News & Ratings for ARYA Sciences Acquisition Corp IV Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ARYA Sciences Acquisition Corp IV and related companies with MarketBeat.com's FREE daily email newsletter.